Photo of Kristen standing and smiling on a beach
Photo of Kristen standing and smiling on a beach

Making time for the moments that matter with VYVGART Hytrulo

Kristen was diagnosed with CIDP in 2020 and began treatment with VYVGART Hytrulo in 2024. Discover how she’s living VYVIDLY™ through everyday wins.

Kristen is a paid spokesperson.

Want to share your CIDP story? Call 1-844-674-3504 to get involved with the CIDP Patient Ambassador Program.

As a mom of three daughters, spending time with my girls has always been a big part of my life. From going antiquing to exploring our favorite theme parks together, we’ve never shied away from a fun outing. Those memories are so special to me—and continuing to make them is a priority.

I’m a very driven person, especially as a physical therapist. Helping people is a passion of mine, and I’m as committed to my clients as I am to myself. So when I was diagnosed with CIDP in 2020, I was determined to find a way to manage my symptoms and make adjustments, so I could keep doing what I loved and sharing those experiences with my girls.

Early symptoms: The moment I knew

Since I was already physically active in my career, it was pretty clear to me when something was physically off. During one of my theme park visits, I was having trouble seeing the parade over the large crowd. When I tried to look over the people in front of me, I noticed that I couldn’t stand on my tippy toes. That was the first physical sign something was wrong. Symptoms became more common after that—like my leg dragging as I walked, or lugging a suitcase through the airport feeling exhausting.

It was time to search for answers, and the search was a long one. After talking to multiple doctors, I finally found one who recognized what I had. By that point, I was just grateful to have a diagnosis, because it meant I had answers. I knew I had CIDP; now I could focus on how to move forward.

Advocating for the right treatment for me

Everyone’s CIDP experience is different. My doctor told me about the various treatment options and explained that while one treatment could work for one person, it might not be the right fit for someone else. I stayed in close communication with him as I tried different treatments so we could determine what would be the best option for me. I wanted something that would give me the time I was missing in my day for the people and activities I love. So I told my doctor, “Look, I need to know my options.” And that’s when he told me about VYVGART Hytrulo.

Headshot of Kristen
Headshot of Kristen

“I’m really seeing meaningful gains! Having the time to make plans might be the biggest gain of all.”

Life with VYVGART Hytrulo

The fact that VYVGART Hytrulo is a once-weekly injection that goes under the skin—not into a vein—was exciting to me. It was an option that I hoped would give me more freedom. And it has. I’m able to better manage my schedule since I don’t feel the burden of planning my life around treatment.

Overall, VYVGART Hytrulo has improved my condition and maintained my arm and leg function. Everyday activities that used to be a challenge are now more manageable—things I took for granted before CIDP, like making my bed or driving. Having the strength to hit the pedal in my car helps me feel empowered again. Plus, I’ve been able to keep up with my exercise routine.

I’m really seeing meaningful gains! Having the time to make plans might be the biggest gain of all. I just went to New York with my family where we did a fair amount of walking, and I was thrilled to see that I was able to keep up and enjoy it!

I used to plan my life around treatment—now I don’t need to do that.

Photo of Kristen looking over a balcony Photo of Kristen looking over a balcony Photo of Kristen looking over a balcony

What’s next?

With the positive impact VYVGART Hytrulo has had on my ability to schedule my time, I can focus on things I enjoy. This includes day trips with my daughter to antique shops, exercising, working with my clients, and enjoying nearby theme parks. Thanks to VYVGART Hytrulo, my adventures can continue.

live VYVIDLY logo
live VYVIDLY logo

Have questions? Call 1-833-VYV-CIDP (1-833-898-2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study results, cost and coverage, and more.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.